Retrospective Viability Study of the PETHEMA-POMCIDEX Clinical Practice Guidelines for the Treatment of Patients With Relapsed and Refractory Multiple Myeloma (RRMM)
Condition(s):Relapsed and Refractory Multiple MyelomaLast Updated:February 5, 2021Completed